ENTRY       D12620                      Drug
NAME        Frexalimab (USAN/INN)
FORMULA     C6492H9964N1704O2030S40
EXACT_MASS  145555.7662
MOL_WEIGHT  145645.3774
SEQUENCE    (Heavy chain)
            EVQLQESGPG LVKPSETLSL TCTVSGDSIT NGFWIWIRKP PGNKLEYMGY ISYSGSTYYN
            PSLKSRISIS RDTSKNQFSL KLSSVTAADT GVYYCAYRSY GRTPYYFDYW GQGTTLTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKAEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HRDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCAVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE
            LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPGK
            (Light chain)
            DIVMTQSPSF LSASVGDRVT ITCKASSNLG HAVAWYQQKP GKSPKLLIYS ASNRYTGVPD
            RFSGSGSGTD FTLTISSLQP EDFADYFCQQ YDDYPYTFGG GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide birdge: H22-H95, H223-L214, H147-H203, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'95, H'223-L'214, H'147-H'203, H'264-H'324, H'370-H'428, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Immunomodulator, Anti-CD40 ligand antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of autoimmune and neurologic diseases
TARGET      TNFSF5 (CD154) [HSA:959] [KO:K03161]
  PATHWAY   hsa04060(959)  Cytokine-cytokine receptor interaction
            hsa04514(959)  Cell adhesion molecules
            hsa04660(959)  T cell receptor signaling pathway
            hsa04672(959)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF5 (CD154)
                 D12620  Frexalimab (USAN/INN)
DBLINKS     CAS: 2515463-86-0
///
